Publication of Cancellation of Entries for Kinds of Medical Devices from the Australian Register of Therapeutic Goods – Minimax Implant Pty Ltd - 194375

Overview

The Therapeutic Goods Act 1989 was enacted to regulate therapeutic goods in Australia, ensuring they are of acceptable quality and safe for use. It establishes a framework for the regulation of therapeutic goods, including medical devices, through the Australian Register of Therapeutic Goods. This Act was introduced to address the need for a comprehensive system to regulate therapeutic goods, ensuring they meet safety, quality, and efficacy standards. The Act empowers the Therapeutic Goods Administration, under the authority of the Secretary to the Department of Health and Ageing, to manage the inclusion and cancellation of therapeutic goods in the Register. The policy objective is to protect public health by ensuring that only therapeutic goods that meet the required standards are available for use in Australia. In this instance, the cancellation of an entry from the Australian Register of Therapeutic Goods highlights the enforcement of compliance with the Essential Principles and Conformity Assessment Procedures for medical devices.

Scope and Application

The Therapeutic Goods Act 1989, under the specific section 41GP, mandates the publication of the cancellation of entries for certain kinds of medical devices from the Australian Register of Therapeutic Goods (ARTG). This Act applies to medical devices that have been included in the ARTG and ensures that these devices comply with the specified conditions for their inclusion. The cancellation of an entry under this section applies to the entities directly involved, such as sponsors and manufacturers of the medical devices, and affects the specific kinds of medical devices identified by their ARTG numbers. The geographic reach of the Act is national, as it pertains to the regulation and oversight of therapeutic goods across Australia. The Act does not explicitly state any exclusions, exemptions, or thresholds for its application, though it is understood that the provisions would apply uniformly to all medical devices registered under the ARTG. The application and interpretation of this Act may be further extended or restricted through subordinate instruments, such as regulations or guidelines, which provide additional detail on the implementation of the legislative provisions.

Key Provisions

The legislation published under section 41GP of the Therapeutic Goods Act 1989 (the Act) announces the cancellation of a specific medical device from the Australian Register of Therapeutic Goods (ARTG). In this instance, the entry for the Driver/extractor medical device, with the ARTG number 194375, sponsored by Minimax Implant Pty Ltd and manufactured by Dentium Co Ltd, has been cancelled (s 41GP). The cancellation took effect on 5 April 2013, following the sponsor's failure to meet the conditions of inclusion, specifically those relating to the Essential Principles and Conformity Assessment Procedures pertinent to this type of device (s 41GN(1)). Under the Therapeutic Goods Act 1989, the primary obligation for the sponsor of a medical device, in this case Minimax Implant Pty Ltd, is to ensure that all conditions of inclusion are strictly adhered to. This includes compliance with the Essential Principles and the applicable Conformity Assessment Procedures, which are designed to protect public health and safety by ensuring that the medical device meets specific standards and requirements before it can be marketed in Australia. The sponsor has the responsibility to provide accurate and complete information about the device, including its intended use, design, and manufacturing processes, and to ensure that the device itself meets the necessary safety and efficacy standards. Failure to comply with the conditions of inclusion can result in the cancellation of the device's entry from the ARTG, as evidenced in this case. The consequences of such cancellation are significant, as the device can no longer be legally supplied, advertised, or represented as a therapeutic good in Australia. This action is taken to protect public health and safety by preventing the use of medical devices that do not meet the required standards. There are no specific offences, penalties, or criminal consequences detailed in this publication; however, the cancellation itself serves as a formal administrative action under the Act, reflecting non-compliance with the regulatory requirements. In summary, section 41GP of the Therapeutic Goods Act 1989 provides the framework for the cancellation of a medical device's entry from the ARTG when the sponsor fails to meet the conditions of inclusion. This specific cancellation of the Driver/extractor device, sponsored by Minimax Implant Pty Ltd and manufactured by Dentium Co Ltd, highlights the importance of adhering to the Essential Principles and Conformity Assessment Procedures. Non-compliance results in the removal of the device from the ARTG, which has significant implications for the sponsor and the public, underscoring the regulatory body's commitment to maintaining high standards for therapeutic goods in Australia.